TOWA Pharmaceutical News

Luye Pharma's Japanese Partner Towa Files New Drug Application for Dementia Patch

Luye Pharma Group's (HKG:2186) partner Towa Pharmaceutical (TYO:4553) filed a new drug application with the Ministry of Health, Labour and Welfare in Japan for Rivastigmine, a Thursday filing with the

MT NewswiresJun 6 07:56 ET

Synbio Pharmaceuticals Research Memo (7): Market share of treaxine (R) is expected to decline moderately due to entry into generic pharmaceuticals

■Other pipeline trends for Synbio Pharmaceuticals＜4582＞ 1. “Treaxine (R)” (generic name: bendamustine hydrochloride) and “treaxine (R)” are anticancer drugs for malignant lymphoma. Malignant lymphoma is a disease in which lymphocytes, which are a type of white blood cell, become cancerous (tumours) and form lumps (tumors) in lymph nodes and organs, and also occurs from lymph nodes distributed throughout the body and organs other than lymph nodes (stomach, intestines, thyroid, spinal cord, lungs, liver, skin, eyes, etc.). Of blood cancer

Fisco JapanMay 30 00:17 ET

Sojitz, Kakaku.com, etc. (additional) Rating

Upgrade-Bullish Code | Stock Name | Securities Company | Conventional | After Change |------|------------|------------|------------|＜6845＞|Azbil |SMBC Nikko | “2” | “1” |＜9506＞|Tohoku Electric Power | Mizuho | “Neutral” | “Buy” | Downgrade-Bearish Code |

Fisco JapanMay 27 22:44 ET

List of Yunlou stocks [Ichimoku equilibrium table/ Yunlou stock list]

○Cloud Top Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime ＜1871＞ PS Mitsubishi 1027 1020.5 1014.5 ＜1926＞ Light Engineering 2016 2015 1964 ＜2109＞ DM Mitsui Sugar 3245 3119.25 3210.5 ＜2117 ＞ Wellness

Fisco JapanMay 26 18:56 ET

Towa Pharmaceutical, Nikkeikin HD, etc. (additional) Rating

Target Stock Price Change Code | Stock Name | Securities Company | Conventional | After Change |------|---------|---------|---------|＜3288＞|Open H | Yamato | 5800 yen | 5900 yen |＜4553＞|Towa Pharmaceuticals | Nomura | 2880 yen | 3000 yen |＜4732＞|USS |SMBC Nikko

Fisco JapanMay 16 22:13 ET

Sony G, 24/3 operating profit down 7.2% to 1,208.8 billion yen, 25/3 forecast 5.5% increase to 1.275 trillion yen

The financial results for the fiscal year ending 2024/3 announced by Sony G ＜6758＞ were sales revenue of 13.20.768 billion yen, up 18.6% from the previous fiscal year, and operating profit of 1,208.8 billion yen, down 7.2% from the same period. As for the financial results for the fiscal year ending 2025/3, we plan that sales revenue will decrease 5.5% from the previous fiscal year to 12.31 trillion yen, and operating profit will increase 5.5% to 1.275 billion yen. It was announced that 1 share will be split into 5 shares using 9/30 as the reference date. Also, it is 2.46% of the number of issued shares (excluding treasury stock)

Fisco JapanMay 14 16:53 ET

Towa Pharmaceutical Co FY Net Y16.17B Vs Net Y2.20B

Towa Pharmaceutical Co. Ltd. (4553.TO) Japan Year Ended March 31 GROUP 2024 2023 Revenue Y227.93 bln Y208.86 bln Operating Profit Y17.65 bln

Dow JonesMay 14 02:01 ET

TOWA Pharmaceutical: Financial Results Supplementary Explanatory Materials for the Fiscal Year Ending March 31, 2024

JPXMay 14 02:00 ET · Announcements

TOWA Pharmaceutical: Financial Results for the Fiscal Year Ending March 31, 2024 [Japanese GAAP] (Consolidated)

JPXMay 14 02:00 ET · Announcements

Convertible Stock List (Part 2) [Parabolic Signal Convertible Stock List]

○List of sales conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1719＞ Ando Hazama 1154 1184 ＜1721＞ Comsys HD 3643 3796 ＜1885＞ Toa Kenshi 1041 1109 ＜1898＞ Century Tokyu 1755 1799 ＜1950＞ Nippon Densetsu 2065 222

Fisco JapanMay 8 18:50 ET

List of Unrivaled Stocks (Part 2) [Ichimoku Equilibrium Chart/Kumoku Stock List]

○List of Unbroken Stocks Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime ＜1786＞ Oriental Shiraishi 376 391.25 378 ＜1871＞ PS Mitsubishi 992 1054 1004 ＜1925＞ Daiwa House 4407 4411 4460.5 ＜1946＞ Toe

Fisco JapanMay 1 18:53 ET

Convertible Stock List (Part 1) [Parabolic Signal Convertible Stock List]

○ Purchase conversion stock list market code stock name closing price SAR Tokyo Stock Exchange Prime ＜2053＞ Chubu Feed 1173 1080 ＜2109＞ DM Mitsui Sugar 3025 2937 ＜2266＞ Rokko Butter 1453 1395 ＜2294＞ Kakiyasu Main Store 3180 3090 ＜2590＞ dyDo 　 　 　 　

Fisco JapanApr 22 19:03 ET

List of Unrivaled Stocks (Part 1) [Ichimoku Equilibrium Chart/Kumoku Stock List]

○Kumojo Stock List Market Code Stock Name Closing Price Advance Span A Advance Span B Tokyo Stock Exchange Prime ＜2301＞ Academic Information 1824 1805 1789 ＜2767＞ Tsuburaya Fee HD 1656 1637.5 1564.5 ＜2884＞ Yoshimura Food 1402 1244 1157.5 ＜3092＞ ZOZO 353

Fisco JapanApr 16 18:43 ET

At the forefront of “Brain Tech”! List of elite stocks winning through fierce development competition ＜Stock Search Top Feature＞

Development competition in the “brain tech” field, which combines neuroscience with cutting-edge technology, is extremely fierce. Startup companies have sprung up one after another in Japan and overseas, and new products and services have appeared, and listed companies are also advancing research and development in anticipation of future commercialization in a market where rapid growth can be expected. It seems that it can be said that related stocks are in a state where energy to undergo transformation is contained.

MinkabuApr 9 06:30 ET

Convertible Stock List [Parabolic Signal Convertible Stock List]

○List of trading stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜2163＞ Altner 2413 2278＜2325＞ NJS 3195 3055 ＜2389＞ digital HD 1188 1082 ＜3104＞ Fujibo HD 4465 4335 ＜3150＞ Grimes 2238 2106 ＜3950＞

FiscoMar 31 18:54 ET

Towa Pharmaceutical Completes Payment for Director Stock Compensation

Towa Pharmaceutical (TYO:4553) completed a share distribution program for restricted stock compensation, according to a filing submitted to the Tokyo Stock Exchange on Friday. The company distributed

MT NewswiresMar 25 04:26 ET

Towa Pharmaceutical Co 9-Mos Net Y11.52B Vs Net Y1.98B

Towa Pharmaceutical Co. Ltd. (4553.TO) Japan Nine Months Ended December 31 GROUP 2023 2022 Revenue Y168.33 bln Y140.41 bln Operating Profit Y13.

Dow JonesFeb 13 01:02 ET

Towa Pharmaceutical Co Sees FY Net Y6.90B

Towa Pharmaceutical Co. Ltd. also released the following forecasts: GROUP Year Ending Mar 2024 Revenue Y216.30 bln Operating Profit Y11.80 bln Pret

Dow JonesNov 13, 2023 01:01 ET

Towa Pharmaceutical Co Sees 1H Parent Pretax Y10.20B

PARENT New Forecast Prior For Year to Sep 2023 Forecast Revenue Y107.30 bln N/A Pretax Profit Y10.20 bln N/A Net Prof

Dow JonesNov 6, 2023 01:00 ET

Towa Pharmaceutical Co 1Q Net Y4.75B Vs Net Y1.37B

Towa Pharmaceutical Co. Ltd. (4553.TO) Japan 1st Quarter Ended June 30 GROUP 2023 2022 Revenue Y54.55 bln Y45.37 bln Operating Profit Y4.10

Dow JonesAug 10, 2023 02:03 ET